Skip to content

Drug interactions

Insulin isophane protamine human + Linagliptin

Severity: Minor

Insulin isophane protamine human and Linagliptin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Linagliptin added to insulin improves control but can increase hypoglycemia risk modestly because both lower glucose. The risk is lower than with sulfonylureas.

What this interaction means in plain words

Insulin isophane protamine human and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Insulin isophane protamine human belongs to Endocrine; Linagliptin belongs to Endocrine.

Evidence level: High

Why it happens

Additive glucose lowering through DPP-4 inhibition raising incretin levels plus exogenous insulin.

What to do

Monitor glucose when starting linagliptin and reduce the insulin dose if hypoglycemia occurs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Insulin isophane protamine human and Linagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Insulin isophane protamine human with Linagliptin?

MediHelp rates the interaction as minor. Insulin isophane protamine human and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Linagliptin added to insulin improves control but can increase hypoglycemia risk modestly because both lower glucose. The risk is lower than with sulfonylureas.

How serious is the interaction between Insulin isophane protamine human and Linagliptin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glucose when starting linagliptin and reduce the insulin dose if hypoglycemia occurs.

What other medicines interact with Insulin isophane protamine human?

MediHelp also lists interactions of Insulin isophane protamine human with, for example, Ethanol, Pioglitazone, Rosiglitazone. The full list is on the Insulin isophane protamine human page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in